Keyphrases
Obstructive Sleep Apnea
86%
Pulmonary Tuberculosis
60%
Diabetes Mellitus Type 2
46%
Tuberculosis Patients
40%
Chronic Obstructive Pulmonary Disease
40%
Jakarta
40%
CHAID
38%
Tuberculosis
37%
Prediction Model
36%
Risk Factors
36%
Pulmonary Capillary Wedge Pressure
33%
Pressure Formula
33%
Risk Prediction Model
33%
Obstructive Sleep Apnea Risk
33%
Circulatory Disease
33%
Chronic Obstructive Pulmonary Disease Patient
33%
Type 2 Diabetes Mellitus (T2DM)
33%
Colloids
33%
Decision Tree Method
33%
Pre-diabetes (pre-DM)
33%
Albumin
33%
Echocardiography
33%
Evidence-based Case Report
33%
Partial Least Squares Structural Equation Modeling (PLS-SEM)
33%
Detection Method
33%
Large-volume Paracentesis
33%
Atrial Fibrillation
33%
DOTS Strategy
33%
Predictive Success
33%
Tuberculosis Treatment
33%
Body Mass Index
25%
Paracentesis-induced Circulatory Dysfunction
22%
Multidrug-resistant Tuberculosis (MDR-TB)
20%
DM Type 2
16%
Obesity
16%
Waist Circumference
15%
Taking Medicine
13%
Nutritional Status
13%
Pyrazinamide
13%
Ethambutol
13%
Success Rate
13%
Berlin Questionnaire
13%
Sleep Hygiene
12%
Blood Pressure
12%
Meta-analysis
11%
Randomized Clinical Trial
11%
Antibiotic Use
11%
Treatment Efficacy
11%
Type 1 Diabetes Mellitus (T1DM)
11%
Non-probability Samples
10%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
66%
Medicine
38%
Partial Least Squares Regression
33%
Obstructive Sleep Apnea
33%
Impaired Glucose Tolerance
33%
Echocardiography
33%
Pulmonary Artery
33%
Short Course Therapy
33%
Tuberculosis Treatment
33%
Extrapulmonary Tuberculosis
33%
Lung Tuberculosis
27%
Drug Resistant Tuberculosis
22%
Multidrug Resistant Tuberculosis
22%
Nutritional Status
22%
Ethambutol
16%
Body Mass Index
16%
Sleep Hygiene
12%
Logistic Regression Analysis
11%
Streptomycin
11%
Isoniazid
11%
Extensively Drug Resistant Tuberculosis
11%
Tuberculostatic Agent
11%
Pyrazinamide
11%
Rifampicin
11%
Infection
11%
Human Immunodeficiency Virus
11%
Diabetes Mellitus
10%
Mycobacterium Tuberculosis
5%
Hormone Synthesis
5%
Stress Hormone
5%
Erythrocyte Sedimentation Rate
5%
Lymphocyte
5%
Isoniazid Plus Pyrazinamide Plus Rifampicin
5%
Neutrophil
5%
Stress (Clinical Finding)
5%
Secondary Data
5%
Oxidative Stress
5%
Pharmacology, Toxicology and Pharmaceutical Science
Sleep Disordered Breathing
100%
Non Insulin Dependent Diabetes Mellitus
66%
Chronic Obstructive Lung Disease
66%
Atrial Fibrillation
33%
Impaired Glucose Tolerance
33%
Tree
33%
D Dimer
33%
Fibrin Monomer
33%
Randomized Clinical Trial
33%
Extrapulmonary Tuberculosis
33%
Lung Tuberculosis
27%
Hetastarch
11%
Infection
11%
Gelatin
11%
Ascites
11%
Dextran
11%
Randomized Controlled Trial
11%
HIV
11%
Diabetes Mellitus
10%
Dyspnea
6%
Antibiotic Agent
6%
Prevalence
5%
Ethambutol
5%
Ischemic Heart Disease
5%
Stress Hormone
5%
Isoniazid Plus Pyrazinamide Plus Rifampicin
5%
Mycobacterium Tuberculosis
5%
Hypoxemia
5%
